Dual-energy X-ray absorptiometry (DXA) has become an indispensable tool in clinical research for its ability to accurately measure bone mineral density, body composition, and fat distribution. With its non-invasive nature and high precision, DXA provides researchers with crucial data for assessing bone health, diagnosing osteoporosis, monitoring changes in body composition due to interventions or diseases, and evaluating the efficacy of treatments.
Moreover, DXA's capability to differentiate between lean mass, fat mass, and bone mineral content makes it invaluable in studying conditions such as obesity, sarcopenia, and metabolic disorders. By offering precise and reliable measurements, DXA empowers researchers to advance the understanding of various diseases and optimize patient care strategies, ultimately contributing to improved health outcomes and quality of life.
At Boston Children’s Hospital, our DXA Bone Density Program collaborates with more than 40 clinical research studies spanning various disciplines, both within and outside our institution. We eagerly anticipate connecting with you to explore how DXA can be integrated into your clinical research endeavors. Here is one example of our ongoing collaborations using DXA:
